Skip to main content
NCBI home page
ACS Omega logoLink to ACS Omega
. 2020 Jun 3;5(23):14186–14193. doi: 10.1021/acsomega.0c02074

Cyclic Organoselenide BODIPY-Based Probe: Targeting Superoxide in MCF-7 Cancer Cells

Kashinath S Madibone †, Pratiksha P Deshmukh †, Ambuja Navalkar ‡, Samir K Maji ‡, Purav M Badani †, Sudesh T Manjare †,*
PMCID: PMC7301547  PMID: 32566887

Abstract

graphic file with name ao0c02074_0012.jpg

All aerobic cells contain reactive oxygen species (ROSs) in balance with biochemical antioxidants. Oxidative stress is developed when this balance gets disturbed because of excessive production of ROSs or depletion of antioxidants. Here, in this work, we have developed the first cyclic diselenide BODIPY-based (organoselenium-containing) probe for the selective detection of superoxide. The probe demonstrates excellent selective response for superoxide over other ROSs with nine-fold increase in fluorescence intensity. The detection limit was found to be 0.924 μM. The plausible “turn-on” mechanism has been proposed based on the spectroscopic and quantum chemical data. Usefulness of the probe for selective detection of superoxide was confirmed in mammalian breast cancer cell lines.

Introduction

In recent decades, organoselenium chemistry has received enhanced attention because of its various important roles, excellent redox properties,1 and relatively low level of cytotoxicity2 compared to inorganic selenium compounds.3 Organoselenium-containing compounds are of increasing importance in enzymology, medicine, and bio-organic chemistry.4 Specially, selenium-containing heterocyclic compounds possess several biological activities, which include anti-inflammatory, antitumor, antifungal, and antioxidant properties.5,6 Additionally, selenium plays an important role at the active site of glutathione peroxidase (GPx)7−10 in the conversion of natural hydrogen peroxide to water.11 Organoselenium-based molecular probes provide reliable detection of biologically important analytes such as reactive oxygen species (ROSs),12−15 reactive nitrogen species,16,17 biothiols,18 amino acids, and so forth in a qualitative and quantitative way because of their redox properties. Production of ROSs is associated with various human disorders19−22 such as Alzheimer’s, Parkinson’s, and cancers where the excess production of ROSs is the major causative factor of the diseases.23,24 ROSs25 include HOCl, •OH, H2O2, O2•–, tBuOOH, tBuO•, and so forth.26 Selective and sensitive detection of such species with fluorescence microscopy requires discrete synthetic molecular designs and facile synthesis, which makes this field challenging and important.27 Superoxide (O2•–) with a short half-life is an important ROS and the detection of which at actual time is crucial but complicated. It is well known that superoxide can elaborate chemistry by combining with NO to produce peroxynitrite which is a versatile and highly potent oxidant as compared to NO and superoxide. This can attack and damage a broad range of biological species.28,29 Cells possess an antioxidant defence system to regulate their internal redox equilibrium and give essential biological function of endogenously produced ROSs, for example, signal transduction, neurotransmission, and blood pressure modulation.20,21,24 Detection of biologically important species using fluorescence techniques is particularly attractive because of its high sensitivity, fast response time, simplicity of implementation, and high potential for imaging in live cells or tissues.30 BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) has well-known characteristics including intense fluorescence with high quantum yield, good photochemical stability, a large extinction coefficient, and so forth.31−33 Biosensing with small molecular probes enables monitoring of biochemical and biomolecular processes in organisms at the cellular level and allows potential applications in various fields from fundamental biological research to clinical diagnostics.34 In recent years, numerous selenium-containing small molecular probes for the detection of ROSs and biothiols have been reported in the literature.1,12,35−38 However, to the best of our knowledge, there are very few reports on selenium-based probes for selective detection of superoxide.39,40 Here, we have designed and synthesized the first cyclic diselenide (heterocyclic)-containing BODIPY-based probe for selective and sensitive detection of superoxide.

Results and Discussion

Synthesis of a cyclic diselenide-containing probe is outlined in Scheme 1. Dipyrromethane 2 was synthesized from the corresponding peri-substituted diselenide-containing naphthaldehyde 1 and pyrrole (25 equiv) with a catalytic amount of trifluoroacetic acid (TFA). The crude product was purified by column chromatography and was characterized by 1H, 13C, and 77Se NMR spectroscopy, mass spectrometry, and elemental analysis (Figures S1–S10). In the 1H NMR spectrum of dipyrromethane 2, the signal for aldehydic proton disappeared and a new signal at δ 5.4 ppm for aliphatic CH proton and three signals for the pyrrole ring were observed. Cyclic diselenide-containing BODIPY probe 3 was synthesized from the reaction of dipyrromethanediselenide intermediate 2 with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) (1 equiv) in DCM followed by addition of triethylamine (10 equiv) and borontrifluoride diethyletherate (BF3·OEt2) (10 equiv) under a nitrogen atmosphere. The crude compound 3 was purified by column chromatography and characterized by 1H, 13C, and 77Se NMR spectroscopy and mass spectrometry (Figures S11–S19). In the 1H NMR spectrum of probe 3, the signal for the aliphatic dipyrromethane proton at δ 5.4 ppm disappeared. Additionally, in the 77Se NMR spectrum, two signals were observed for chemically different selenium, one at δ 410 ppm and another significantly downfield at δ 449 ppm, when compared with dipyrromethane (δ 411 and δ 434 ppm, respectively), which further confirmed the formation of cyclic diselenide-containing BODIPY probe 3.

Scheme 1. Synthesis of Cyclic Diselenide-Containing BODIPY Probe 3.

Scheme 1

Open in a new tab

The successful synthesis of the first cyclic diselenide BODIPY-based probe increases the curiosity about the reactivity of the probe for selective and sensitive detection of biologically important analytes. Therefore, the spectroscopic properties of probe 3 were studied in DMSO/water (30:70). The probe was screened with various ROSs such as O2•–, H2O2, tBuOOH, –OCl, •OH, and tBuO• in water using a UV–visible spectrophotometer and spectrofluorometer. Probe 3 shows strong green turn-on fluorescence upon addition of KO2 over the other ROSs (H2O2, tBuOOH, –OCl, •OH, and tBuO•). It is already reported in the literature that KO2 in aqueous medium can be used as superoxide.41

The probe was incubated with different ROSs for 15 min and the quantitative absorbance and emission spectra were recorded. The probe absorbed at 506 nm and emitted at 521 nm with almost negligible emission intensity (Figures S22, 1, and 2). The molar extinction coefficient of the probe was found to be 16,000 M–1·cm–1. High increase in fluorescence intensity of the probe in presence of superoxide was observed (from 1.375 for the probe to 647.949 for the probe with superoxide). The quantum yield of the probe and its oxidized form was calculated according to the literature.36 The fluorescence quantum yield of probe 3 was increased from 2 to 17 percent (nine-fold increase in fluorescence intensity, calculated from quantum yield).

Figure 1.

Figure 1

Open in a new tab

Emission spectra of the probe (20 μM, DMSO/water: v/v = 30:70) with ROSs (O2•–, H2O2, tBuOOH, –OCl, •OH, and tBuO•) (33.3 equiv) incubated for 15 min at RT (λex = 506 nm and λem = 521 nm).

Figure 2.

Figure 2

Open in a new tab

Emission spectra of the probe alone (20 μM, DMSO/water: v/v = 30:70) and with KO2 incubated for 15 min at RT.

The interference study of probe 3 was carried out in the presence of superoxide along with addition of other ROSs. It was observed that there is no remarkable change in fluorescence intensity of the probe with superoxide in presence of other ROSs. This suggests that there is no interference of other ROSs in the detection of superoxide using probe 3 (Figure S23).

In increasing concentration study, with gradual increase in superoxide concentration, linear increase in fluorescence intensity of probe 3 was observed (Figure 3). The detection limit of the probe was determined by plotting the graph of emission intensity versus concentration of superoxide. The detection limit of 3 was found to be 0.924 μM (Figure S24).

Figure 3.

Figure 3

Open in a new tab

Emission spectra of the probe (20 μM, DMSO/water: v/v = 30:70) with increasing concentration of KO2 (0–666.67 μM) incubated for 15 min at RT (λex = 506 nm and λem = 521 nm) (the experiment was repeated three times).

The kinetic study of the probe was conducted by adding superoxide (20 μL, 666.67 μM) to the probe solution (3 mL, 20 μM), and the spectrum was recorded for 1 h (Figure 4). It shows steady increase in fluorescence intensity up to 15 min and then saturated. This study suggests that the probe has good fluorescence stability for a longer time.

Figure 4.

Figure 4

Open in a new tab

Time-dependent emission spectrum of probe 3 with KO2 (666.67 μM) in DMSO/water (v/v = 30:70) at λem = 521 nm.

In order to understand the redox capacity of selenium in probe 3, the probe was oxidized with superoxide and further treated with biothiols such as glutathione, N-acetyl-l-cysteine, homocysteine, and l-cysteine. The result obtained shows significant decrease in fluorescence intensity of the probe (Figure S25).

Finally, to support the “turn-on” event that occurred for the detection of superoxide with probe 3, the reaction of probe 3 with KO2 (33.33 equiv) was carried out; the mass spectrum and the 1H NMR spectrum were recorded. 1H NMR spectroscopy revealed that the protons attached to the pyrrole and naphthalene of the probe have been shifted after reaction with KO2 (Figures S20 and 5). Additionally, from the mass spectrum analysis, the isotopic pattern of selenium with one oxygen was observed at m/z 491 [MO – 1]+ (Figure S21), which suggested the monoxidation of probe 3. However, there were two probable Se sites of oxidation. In order to ascertain the most active site for the oxidation, density functional theory (DFT) calculations at the B3LYP/6-311G*(d,p) level of theory were performed. Figure 6 displays the optimized structures of the probe. NBO charge analysis suggested a positive charge density of 0.286e and 0.263e at Se1 and Se2, respectively. Additionally, 77Se NMR of probe 3 showed peaks at 449 and 410 ppm for Se1 (proximal Se) and Se2 (distal Se), respectively (Figure S13), indicating that Se1 was more electron deficient than Se2. Therefore, because of higher positive charge density on Se1, it was expected that the nucleophile (O2•–) would attack on it and Se1 will get oxidized to form Se=O and attain oxidation state Se(IV). This data supported the proposed plausible mechanism as shown in Scheme 2 and concluded that because of oxidation of selenium by superoxide, there was no availability of electrons at the selenium center for transfer from cyclic diselenide to the BODIPY core. Hence, the photoinduced electron transfer process was blocked.39 This was further confirmed by the analysis of frontier molecular orbitals (FMOs) of the probe and its oxidized form (Figure 7). The highest occupied molecular orbital (HOMO) of the probe revealed higher electron density on the naphthalene core, while in the low unoccupied molecular orbital (LUMO), electrons were localized at the BODIPY core. Migration of electrons from the HOMO to LUMO suggested the quenching state of the probe.42 Upon oxidation, FMOs suggested retention of electron density on the HOMO and LUMO of the BODIPY core; thereby, the probe showed magnificent increase in fluorescence intensity.

Figure 5.

Figure 5

Open in a new tab

1H NMR spectra of (a) probe 3 and (b) probe 3 + KO2.

Figure 6.

Figure 6

Open in a new tab

DFT-optimized structure of the probe.

Scheme 2. Proposed Plausible Mechanism of the “Turn-On” Event.

Scheme 2

Open in a new tab

Figure 7.

Figure 7

Open in a new tab

HOMO and LUMO of (a) probe 3 and (b) oxidized form of probe 3 in gas phase calculations (B3LYP method and 6-311 G * (d,p) basis set).

Cytotoxicity Assay

To check the utility of the probe for selective detection of superoxide in cells, the MCF-7 mammalian breast cancer cell line was chosen. First, the MTT cell viability assay was carried out to understand the cytotoxicity of the probe. It was performed with a range of probe concentrations (1, 5, 10, 20, and 100 μM). The probe showed good permeability and no cytotoxicity was observed. This study confirmed that the probe can be internalized without cellular damage (Figure 8).

Figure 8.

Figure 8

Open in a new tab

Cell viability assay of MCF-7 cells preincubated for 1 h with probe 3 (1, 5, 10, 20, 50, and 100 μM concentrations).

Cell Imaging

To determine the selectivity of probe 3 inside living cells, treatment of the MCF-7 cell line (human breast cancer cells) with the probe was carried out. MCF-7 cells were incubated with phorbol-12-myristate-13-acetate (PMA) which produces superoxide inside the cells. As a control, only MCF-7 cells were observed under blue laser of fluorescence microscopy, which did not show any native fluorescence inside the cells. In the PMA control, no remarkable fluorescence inside the cells was observed. MCF-7 cells were seeded in a 24-well plate (∼1 × 104 cells per well) in Dulbecco’s modified Eagle’s medium (DMEM) on glass coverslips. The cells were treated with probe 3 dissolved in DMSO and PMA (1 μM) was added to induce ROS production. The cells were observed under a Leica DMi8 microscope in the DIC and fluorescence mode, and a strong green fluorescence signal was observed inside the cells (Figure 9). These results confirmed the ability of the probe for selective detection of superoxide inside the cells.

Figure 9.

Figure 9

Open in a new tab

Fluorescence microscopic images of breast cancer MCF-7 cells. Bright-field and fluorescence images of (a) MCF-7 cells, (b) MCF-7 cells with PMA, (c) MCF-7 cells incubated with probe 3, and (d) MCF-7 cells incubated with probe 3 and PMA (PMA generates superoxide in the cell).

Conclusions

The first cyclic diselenide-containing BODIPY-based probe was synthesized and characterized. The molecule was found to be a potential small molecular probe for selective and sensitive (nine-fold increase in fluorescence intensity) detection of superoxide. The detection limit of the probe was found to be 0.924 μM and the quantum yield of the oxidized product was calculated as 17 percent. The plausible mechanism of the turn-on event has been proposed and supported with spectroscopic data and quantum chemical calculations. The quantum chemical calculations indicated that the proximal Se gets oxidized in comparison with distal Se. Finally, the utility of the probe for selective detection of superoxide in mammalian breast cancer cell lines was explored, which suggested that the probe can be used for the in vivo detection of superoxide. This study will explore the possibilities of using organoselenium molecules in medicine for monitoring of cancer.

Experimental Section

Materials

All chemicals used for synthesis and photophysical study (analytical grade) were procured from commercial sources and used without further purification. Column chromatography was performed on silica gel (60–120). The 1H NMR spectra were recorded in CDCl3 with Bruker 300 and 400 MHz instruments. The frequency for the 13C nucleus was 75.47 MHz for the 300 MHz instrument. The frequency for the 77Se nucleus was 76.34 MHz for the 400 MHz instrument. Tetramethylsilane was used as an internal standard for 1H NMR and 13C NMR spectroscopy and Ph2Se2 was used as the external standard for 77Se NMR spectroscopy. All ROSs were purchased from Sigma-Aldrich and used without further purification. Mass spectra were obtained using Maxis Impact (BRUKER). UV spectra were recorded with Shimadzu UV2450. The fluorescence spectra were obtained using Shimadzu RF5301PC. The fluorescence microscopic images were obtained using Leica DMi8.

Synthesis of Compound 2

The reaction mixture of naphthalene-1,8-diselenide-2-carboxaldehyde 1 (0.400 g, 1.280 mmol) and 2.2 mL of pyrrole (2.146 g, 32 mmol) with a catalytic amount of TFA was stirred for 12 h under a nitrogen atmosphere. The reaction was monitored by thin-layer chromatography (TLC) and the crude product was purified by column chromatography using DCM/pet ether (1:1). Yield of 2 was 0.433 g (79%). Spectroscopic data for compound 2: 1H NMR (300 MHz, CDCl3): δ 8.01 (bS, 2H), 7.47-7.41 (m, 2H), 7.34 (d, 1H), 7.23-7.18 (m, 1H), 7.03 (d, 1H), 6.68 (q, 2H), 6.16 (q, 2H), 6.04 (bs, 2H), 5.41 (s, 1H). 13C NMR (75.4 MHz, CDCl3): δ 141.0, 140.2, 138.0, 136.6, 135.9, 131.4, 129.3, 128.6, 127.2, 125.0, 123.9, 123.2, 121.8, 118.7, 118.3, 117.6, 116.8, 109.0, 108.7, 44.6. 77Se NMR (76.3 MHz, CDCl3): δ 411, 434. ESI–MS: calcd for C19H14N2Se2, 429.95; found m/z, 428.9410 (M – H)+.

Synthesis of Probe 3

Naphthalene-1,8-diselenide-2-dipyrromethane 2 (0.500 g, 1.168 mmol) and DDQ (0.265 g, 1.168 mmol) were stirred in dry DCM. The reaction was continued until the complete consumption of dipyrromethane. The progress of the reaction was monitored by TLC. After 1 h of stirring, 1.6 mL of triethylamine (1.180 g, 11.680 mmol) was added followed by addition of 1.4 mL of BF3·OEt2 (1.657 g, 11.680 mmol). The reaction was stirred for 3 h. The reaction mixture was concentrated under vacuum and the crude product was purified by column chromatography in DCM:pet ether (1:1). The yield of probe 3 was 0.148 g (26%) (mp 202 °C). Spectroscopic Data for probe 3: 1H NMR (300 MHz, CDCl3): δ 7.96 (bs, 2H), 7.62 (d, 1H), 7.56 (d, 1H), 7.44 (d, 1H), 7.38-7.35 (t, 1H), 7.22 (d, 1H), 6.99 (d, 2H), 6.50 (d, 2H). 13C NMR (100.62 MHz, CDCl3): δ 145.5, 143.6, 141.8, 138.0, 137.8, 133.6, 131.1, 129.1, 128.6, 127.5, 124.5, 123.6, 122.4, 118.9. 77Se NMR (76.3 MHz, CDCl3): δ 449 (Se1), 410 (Se2). ESI–MS: calcd for C19H11BF2N2Se2 + Na, 498.92; found m/z, 498.9219 (M + Na)+.

Photophysical Study

The spectrophotometric titration of probe 3 was measured in DMSO–water, as the concentration of stock solution was 20 μM. All (0.1 M) ROSs (O2•–, H2O2, tBuOOH, –OCl, •OH, and tBuO•) were prepared in distilled water. Spectral data were recorded after 15 min of incubation of the probe with ROSs. The excitation wavelength of the probe was 506 nm.

Screening and Sensitivity of Probe 3 with ROSs

Screening of probe 3 was carried out with various ROSs (O2•–, H2O2, tBuOOH, –OCl, •OH, and tBuO•). In this experiment, 3 mL of probe 3 (20 μM) with ROSs (33.33 equiv) in water was taken. The photometric titration experiment was performed by adding probe 3 (20 μM) with increasing concentration of KO2 (0-666.67 μM) in each vial. UV–vis and fluorescence measurements were taken after incubation of 15 min.

Interference Study

This experiment was performed with 3 mL of probe 3 (20 μM) and 666.67 μM KO2 (0.1 M) in every vial which previously contained 666.67 μM of other ROSs, for example, H2O2, tBuOOH, –OCl, •OH, and tBuO• (0.1 M), in water. Fluorescence readings were recorded after incubation of 15 min.

Determination of the Detection Limit

The detection limit was calculated on the basis of the increasing concentration curve of fluorescence. The fluorescence emission spectrum of probe 3 was taken three times and the standard deviation of the blank measurement was calculated. To calculate the slope, the fluorescence intensity at 521 nm was plotted as a concentration of KO2. The detection limit was calculated using the following equation

graphic file with name ao0c02074_m001.jpg

where σ stands for standard deviation of 10 blank measurements and k is the slope between the fluorescence intensity and concentration of KO2.

Computational Study

The quantum chemical calculations were performed based on DFT using Gaussian 09 software at the B3LYP/6-311G*(d,p) level of theory. The structure of the probe and its oxidized form were optimized in the gas phase. The NBO analysis and HOMO–LUMO calculations were carried out in Gaussian 09 software.

Cell Viability Assay

MCF-7 human breast cancer cells were seeded at a density of ∼1 × 104 cells in a 96-well cell culture plate and incubated overnight. The toxicity of the probe was determined using various concentrations (1, 5, 10, 20, 50, and 100 μM). DMSO and cell-free media were used as controls. The plate was incubated for 1 h at 37 °C and MTT dye (10 μL, 5 mg/mL) was added to each well and further incubated for 4 h. Finally, after addition of DMF-SDS mixture (100 μL), the cells were incubated overnight. The absorbance was measured using a SpectraMax M2 plated reader at 560 nm with background scattering at 690 nm.

Cell Culture and Fluorescence Imaging

MCF-7 human breast cancer cells were seeded in a 24-well plate at a density of 1 × 104 cells per well in DMEM on glass coverslips and incubated overnight at 37 °C in 5% CO2. Later, MCF-7 cells were treated with the probe (100 μM) dissolved in DMSO followed by the addition of PMA (1 μM) to induce ROS production. Finally, the cells were incubated for 1 h and fixed using 4% para-formaldehyde for 20 min. DABCO (1,4-diazobicyclo-2,2,2-octane) medium was used to mount the coverslips. Fluorescent images were obtained on a Leica DMi8 microscope in the DIC and fluorescence mode.

Acknowledgments

S.T.M. and P.P.D. acknowledge the Science and Engineering Research Board (SERB), Govt. of India, New Delhi, for financial support (YSS/2014/000726) and K.S.M. acknowledges the UGC for SRF support.

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsomega.0c02074.

  • Schemes, experimental data, NMR, mass, absorption spectra, fluorescence spectra, and biological details (PDF)

Author Contributions

K.S.M. and P.P.D. contributed equally to this publication.

The authors declare no competing financial interest.

Supplementary Material

ao0c02074_si_001.pdf (2MB, pdf)

References

  1. Lou Z.; Li P.; Han K. Redox-responsive fluorescent probes with different design strategies. Acc. Chem. Res. 2015, 48, 1358–1368. 10.1021/acs.accounts.5b00009. [DOI] [PubMed] [Google Scholar]
  2. Schwarz K.; Foltz C. M. Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J. Am. Chem. Soc. 1957, 79, 3292–3293. 10.1021/ja01569a087. [DOI] [PubMed] [Google Scholar]
  3. Nogueira C. W.; Zeni G.; Rocha J. B. T. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem. Rev. 2004, 104, 6255–6286. 10.1021/cr0406559. [DOI] [PubMed] [Google Scholar]
  4. Mugesh G.; du Mont W.-W.; Sies H. Chemistry of biologically important synthetic organoselenium compounds. Chem. Rev. 2001, 101, 2125–2180. 10.1021/cr000426w. [DOI] [PubMed] [Google Scholar]
  5. Arsenyan P.; Rubina K.; Shestakova I.; Domracheva I. 4-Methyl-1,2,3-selenadiazole-5-carboxylic acid amides: antitumor action and cytotoxic effect correlation. Eur. J. Med. Chem. 2007, 42, 635–640. 10.1016/j.ejmech.2006.12.004. [DOI] [PubMed] [Google Scholar]
  6. Bartolini D.; Sancineto L.; Fabro de Bem A.; Tew K. D.; Santi C.; Radi R.; Toquato P.; Galli F. Selenocompounds in cancer therapy: an overview. Adv. Cancer Res. 2017, 136, 259–302. 10.1016/bs.acr.2017.07.007. [DOI] [PubMed] [Google Scholar]
  7. Nascimento V.; Alberto E. E.; Tondo D. W.; Dambrowski D.; Detty M. R.; Nome F.; Braga A. L. GPx-like activity of selenides and selenoxides: experimental evidence for the involvement of hydroxy perhydroxy selenane as the active species. J. Am. Chem. Soc. 2012, 134, 138–141. 10.1021/ja209570y. [DOI] [PubMed] [Google Scholar]
  8. Selvakumar K.; Shah P.; Singh H. B.; Butcher R. J. Synthesis, structure, and glutathione peroxidase-like activity of amino acid containing ebselen analogues and diaryl diselenides. Chem.—Eur. J. 2011, 17, 12741–12755. 10.1002/chem.201100930. [DOI] [PubMed] [Google Scholar]
  9. Iwaoka M.; Tomoda S. A model study on the effect of an amino group on the antioxidant activity of glutathione peroxidase. J. Am. Chem. Soc. 1994, 116, 2557–2561. 10.1021/ja00085a040. [DOI] [Google Scholar]
  10. Mukherjee A. J.; Zade S. S.; Singh H. B.; Sunoj R. B. Organoselenium chemistry: role of intramolecular interactions. Chem. Rev. 2010, 110, 4357–4416. 10.1021/cr900352j. [DOI] [PubMed] [Google Scholar]
  11. Mugesh G.; Panda A.; Singh H. B.; Punekar N. S.; Butcher R. J. Glutathione peroxidase-like antioxidant activity of diaryl diselenides: a mechanistic study. J. Am. Chem. Soc. 2001, 123, 839–850. 10.1021/ja994467p. [DOI] [PubMed] [Google Scholar]
  12. Manjare S. T.; Kim Y.; Churchill D. G. Selenium- and tellurium-containing fluorescent molecular probes for the detection of biologically important analytes. Acc. Chem. Res. 2014, 47, 2985–2998. 10.1021/ar500187v. [DOI] [PubMed] [Google Scholar]
  13. Chen W.; Bay W. P.; Wong M. W.; Huang D. Selenium Blue-α and -β: turning on the fluorescence of a pyrenyl fluorophore via oxidative cleavage of the Se–C bond by reactive oxygen species. Tetrahedron Lett. 2012, 53, 3843–3846. 10.1016/j.tetlet.2012.05.022. [DOI] [Google Scholar]
  14. Li G.; Zhu D.; Liu Q.; Xue L.; Jiang H. A Strategy for highly selective detection and imaging of hypochlorite using selenoxide elimination. Org. Lett. 2013, 15, 2002–2005. 10.1021/ol4006823. [DOI] [PubMed] [Google Scholar]
  15. Manjare S. T.; Kim J.; Lee Y.; Churchill D. G. Facile meso-BODIPY Annulation and Selective Sensing of Hypochlorite in Water. Org. Lett. 2014, 16, 520–523. 10.1021/ol403405n. [DOI] [PubMed] [Google Scholar]
  16. Wang B.; Yu F.; Li P.; Sun X.; Han K. A BODIPY fluorescence probe modulated by selenoxide spirocyclization reaction for peroxynitrite detection and imaging in living cells. Dyes Pigm. 2013, 96, 383–390. 10.1016/j.dyepig.2012.09.006. [DOI] [Google Scholar]
  17. Yu F.; Li P.; Wang B.; Han K. Reversible near-infrared fluorescent probe introducing tellurium to mimetic glutathione peroxidase for monitoring the redox cycles between peroxynitrite and glutathione in vivo. J. Am. Chem. Soc. 2013, 135, 7674–7680. 10.1021/ja401360a. [DOI] [PubMed] [Google Scholar]
  18. Zeng X.; Zhang X.; Zhu B.; Jia H.; Yang W.; Li Y.; Xue J. A colorimetric and ratiometric fluorescent probe for quantitative detection of GSH at physiologically relevant levels. Sens. Actuators, B 2011, 159, 142–147. 10.1016/j.snb.2011.06.062. [DOI] [Google Scholar]
  19. Valko M.; Leibfritz D.; Moncol J.; Cronin M. T. D.; Mazur M.; Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44–84. 10.1016/j.biocel.2006.07.001. [DOI] [PubMed] [Google Scholar]
  20. Dickinson B. C.; Chang C. J. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat. Chem. Biol. 2011, 7, 504–511. 10.1038/nchembio.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wardman P. Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: Progress, pitfalls, and prospects. Free Radic Biol. Med. 2007, 43, 995–1022. 10.1016/j.freeradbiomed.2007.06.026. [DOI] [PubMed] [Google Scholar]
  22. Que E. L.; Domaille D. W.; Chang C. J. Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging. Chem. Rev. 2008, 108, 1517–1549. 10.1021/cr078203u. [DOI] [PubMed] [Google Scholar]
  23. Kepp K. P. Bioinorganic Chemistry of Alzheimer’s disease. Chem. Rev. 2012, 112, 5193–5239. 10.1021/cr300009x. [DOI] [PubMed] [Google Scholar]
  24. Yap Y. W.; Whiteman M.; Cheung N. S. Chlorinative stress: An under appreciated mediator of neurodegeneration?. Cell. Signal. 2007, 19, 219–228. 10.1016/j.cellsig.2006.06.013. [DOI] [PubMed] [Google Scholar]
  25. Murphy M. P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417, 1–13. 10.1042/bj20081386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Smith L. L. oxygen, oxysterols, ouabain, and ozone: a cautionary tale. Free Radical Bio. Med. 2004, 37, 318–324. 10.1016/j.freeradbiomed.2004.04.024. [DOI] [PubMed] [Google Scholar]
  27. de Silva A. P.; Gunaratne H. Q. N.; Gunnlaugsson T.; Huxley A. J. M.; McCoy C. P.; Rademacher J. T.; Rice T. E. Signaling recognition events with fluorescent sensors and switches. Chem. Rev. 1997, 97, 1515–1566. 10.1021/cr960386p. [DOI] [PubMed] [Google Scholar]
  28. Pryor W. A.; Squadrito G. L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 1995, 268, L699–L722. 10.1152/ajplung.1995.268.5.l699. [DOI] [PubMed] [Google Scholar]
  29. Cross C. E.; Halliwell B.; Borish E. T.; Pryor W. A.; Ames B. N.; Saul R. L.; Mccord J. M.; Harman D. Oxygen radicals and human disease. Ann. Intern. Med. 1987, 107, 526–545. 10.7326/0003-4819-107-4-526. [DOI] [PubMed] [Google Scholar]
  30. Guo Z.; Park S.; Yoon J.; Shin I. Recent progress in the development of near-infrared fluorescent probes for bioimaging applications. Chem. Soc. Rev. 2014, 43, 16–29. 10.1039/c3cs60271k. [DOI] [PubMed] [Google Scholar]
  31. Loudet A.; Burgess K. BODIPY dyes and their derivatives: syntheses and spectroscopic properties. Chem. Rev. 2007, 107, 4891–4932. 10.1021/cr078381n. [DOI] [PubMed] [Google Scholar]
  32. Ulrich G.; Ziessel R.; Harriman A. The chemistry of fluorescent bodipy dyes: versatility unsurpassed. Angew. Chem., Int. Ed. 2008, 47, 1184–1201. 10.1002/anie.200702070. [DOI] [PubMed] [Google Scholar]
  33. Bessette A.; Hanan G. S. Design, synthesis and photophysical studies of dipyrromethene-based materials: insights into their applications in organic photovoltaic devices. Chem. Soc. Rev. 2014, 43, 3342–3405. 10.1039/c3cs60411j. [DOI] [PubMed] [Google Scholar]
  34. Rzeski W.; Matysiak J.; Kandefer-Szerszeń M. Anticancer, neuroprotective activities and computational studies of 2-amino-1,3,4-thiadiazole based compound. Bioorg. Med. Chem. 2007, 15, 3201–3207. 10.1016/j.bmc.2007.02.041. [DOI] [PubMed] [Google Scholar]
  35. Wu D.; Chen L.; Kwon N.; Yoon J. Fluorescent probes containing selenium as a guest or host. Chem 2016, 1, 674–698. 10.1016/j.chempr.2016.10.005. [DOI] [Google Scholar]
  36. Mulay S. V.; Choi M.; Jang Y. J.; Kim Y.; Jon S.; Churchill D. G. Enhanced fluorescence turn-on imaging of hypochlorous acid in living immune and cancer cells. Chem.—Eur. J. 2016, 22, 9642–9648. 10.1002/chem.201601270. [DOI] [PubMed] [Google Scholar]
  37. Mulay S. V.; Yudhistira T.; Choi M.; Kim Y.; Kim J.; Jang Y. J.; Jon S.; Churchill D. G. Substituent effects in bodipy in live cell imaging. Chem.—Asian J. 2016, 11, 3598–3605. 10.1002/asia.201601400. [DOI] [PubMed] [Google Scholar]
  38. Liu S.-R.; Wu S.-P. Hypochlorous acid turn-on fluorescent probe based on oxidation of diphenyl selenide. Org. Lett. 2013, 15, 878–881. 10.1021/ol400011u. [DOI] [PubMed] [Google Scholar]
  39. Manjare S. T.; Kim S.; Heo W. D.; Churchill D. G. Selective and sensitive superoxide detection with a new diselenide-based molecular probe in living breast cancer cells. Org. Lett. 2014, 16, 410–412. 10.1021/ol4033013. [DOI] [PubMed] [Google Scholar]
  40. Deshmukh P. P.; Navalkar A.; Maji S. K.; Manjare S. T. Phenylselenyl containing turn-on dibodipy probe for selective detection of superoxide in mammalian breast cancer cell line. Sens. Actuators, B 2019, 281, 8–13. 10.1016/j.snb.2018.10.072. [DOI] [Google Scholar]
  41. Lu X.; Lin G.; Dong X.; Zhao W.; Chen Z. Response to Comment on “Water-Soluble Fluorescent Probe with Dual Mitochondria/Lysosome Targetability Superoxide Detection in Live Cells and in Zebrafish Embryos”. ACS Sens. 2019, 4, 3084–3087. 10.1021/acssensors.9b01507. [DOI] [PubMed] [Google Scholar]
  42. Chou C.-Y.; Liu S.-R.; Wu S.-P. A highly selective turn-on fluorescent sensor for Cu(II) based on an NSe2 chelating moiety and its application in living cell imaging. Analyst 2013, 138, 3264–3270. 10.1039/c3an00286a. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ao0c02074_si_001.pdf (2MB, pdf)

Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES